Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer

Carcinogenesis

Volumn 21, Issue 2, 2000, Pages 147-151

  Bianco, Tina ^a,b   Chenevix Trench, Georgia ^c   Walsh, David C A ^b   Cooper, John E ^a   Dobrovic, Alexander ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033970096     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.2.147     Document Type: Article

References (43)

1. Bird, A.P. (1986) CpG-rich islands and the function of DNA methylation. Nature, 321, 209-213.
2. Gardiner-Garden, M. and Frommer, M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol., 196, 261-82.
3. Mohandas, T., Sparkes, R.S. and Shapiro, L.J. (1981) Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science, 211, 393-396.
4. Dobrovic, A., Gareau, J.L., Ouellette, G. and Bradley, W.E.C. (1988) DNA methylation and genetic inactivation at the thymidine kinase locus: two different mechanisms for silencing autosomal genes. Somat. Cell Mol. Genet., 14, 55-68.
5. Yisraeli, J., Frank, D., Razin, A. and Cedar, H. (1988) Effect of in vitro DNA methylation on beta-globin gene. Proc. Natl Acad. Sci. USA, 85, 4638-4642.
6. Feinberg, A.P. and Vogelstein, B. (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature, 301, 89-92.
7. Jones, P.A. (1996) DNA methylation errors and cancer. Cancer Res., 56, 2463-2467.
8. Laird, P.W. and Jaenisch, R. (1996) The role of DNA methylation in cancer genetics and epigenetics. Annu. Rev. Genet., 30, 441-464.
9. Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M. and Issa, J.P. (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72, 141-196.
10. Greger, V., Passarge, E., Höpping, W., Messmer, E. and Horsthemke, B. (1989) Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet., 83, 155-158.
11. Sakai, T., Toguchid, J., Ohtani, N., Yandell, D.W., Rapaport, J.M. and Dryja, T.P. (1991) Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet., 48, 880-888.
12. Greger, V., Debus, N., Lohmann, D., Höpping, W., Passarge, E. and Horsthemke, B. (1994) Frequency and parental origin of hypermethylated RBI alleles in retinoblastoma. Hum. Genet., 94, 491-496.
13. Ohtani-Fujita, N., Dryja, T.P., Rapaport, J.M., Fujita, T., Matsumura, S., Ozasa, K., Watanabe, Y., Hayashi, K., Maeda, K., Kinoshita, S., Matsumura, T., Ohnishi, Y., Hotta, Y., Takahashi, R., Kato, M.V., Ishizaki, K., Sasaki, M.S., Horsthemke, B., Minoda, K. and Sakai, T. (1997) Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet. Cytogenet., 98, 43-49.
14. Ohtani-Fujita, N., Fujita, T., Aoike, A., Osifchin, N.E., Robbins, P.D. and Sakai, T. (1993) CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene, 8, 1063-1067.
15. Herman, J.G., Latif, F., Weng, Y., Lerman, M.I., Zbar, B., Liu, S., Samid, D., Duan, D.-S.R., Gnarra, J.R., Linehan, W.M. and Baylin, S.B. (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl Acad. Sci. USA, 91, 9700-9704.
16. INK4B1. Cancer Res., 56, 722-727.
17. Ng, M.H.L., Chung, Y.F., Lo, K.W., Wickham, N.M.R., Lee, J.C.K. and Huang, D.P. (1997) Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood, 89, 2500-2506.
18. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692.
19. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 15, 4525-4530.
20. Gonzalez-Zulueta, M., Bender, C.M., Yang, A.S., Nguyen, T.D., Beart, R.W., Van Tornout, J.M. and Jones, P.A. (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535.
21. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P.K., Norris, F.H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, JC., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A. and Skolnick, M.H. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
22. Smith, S.A., Easton, D.F., Evans, D.G. and Ponder, B.A. (1992) Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet., 2, 128-31.
23. Futreal, P.A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, LM., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Söderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehart, J.D., Marks, J., Ballinger, D.G., Barrett, J.C., Skolnick, M.H., Kamb, A. and Wiseman, R. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122.
24. Merajver, S.D., Pham, T.M., Caduff, R.F., Chen, M., Poy, E.L., Cooney, K.A., Weber, B.L., Collins, F.S., Johnston, C. and Frank, T.S. (1995) Somatic mutations in the BRCA1 gene is sporadic ovarian tumours. Nature Genet., 9, 439-443.
25. Hosking, L., Trowsdale, J., Nicolai, H., Solomon, E., Foulkes, W., Stamp, G., Signer, E. and Jeffreys, A. (1995) A somatic BRCA1 mutation in an ovarian tumour. Nature Genet., 9, 343-344.
26. Takahashi, H., Behbakht, K., McGovern, P.E., Chiu, H.C., Couch, F.J., Weber, B.L., Friedman, L.S., King, M.C., Furusato, M., LiVolsi, V.A., Menzin, A.W., Liu, PC., Benjamin, I., Morgan, M.A., King, S.A., Rebane, B.A., Cardonick, A., Mikuta, J.J., Rubin, S.C. and Boyd, J. (1995) Mutation analysis of the BRCA2 gene in ovarian cancers. Cancer Res., 55, 2998-3002.
27. Thompson, M.E., Jensen, R.A., Obermiller, P.S., Page, D.L. and Holt, J.T. (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet., 9, 444-150.
28. Rice, J.C., Massey-Brown, K.S. and Futscher, B.W. (1998) Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene, 17, 1807-1812.
29. Magdinier, F., Ribieras, S., Lenoir, G.M., Frappart, L. and Dante, R. (1998) Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene, 17, 3169-3176.
30. Taylor, J., Lymboura, M., Pace, P.E., A'hern, R.P., Desai, A.J., Shousha, S., Coombes, R.C. and Ali, S. (1998) An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer, 79, 334-342.
31. Wilson, C.A., Ramos, L., Villasenor, MR., Anders, K.H., Press, M.F., Clarke, K., Karlan, B., Chen, J.J., Scully, R., Livingston, D., Zuch, R.H., Kanter, M.H., Cohen, S., Calzone, F.J. and Slamon, D.J. (1999) Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nature Genet., 21, 236-240.
32. Holt, J.T., Thompson, M.E., Szabo, C., Robinson-Benion, C., Arteaga, C.L., King, M.C. and Jensen, R.A. (1996) Growth retardation and tumour inhibition by BRCA1. Nature Genet., 12, 298-302.
33. Dobrovic, A. and Simpfendorfer, D. (1997) Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res., 57, 3347-3350.
34. Mancini, D.N., Rodenhiser, D.I., Ainsworth, P.J., O'Malley, F.P., Singh, S.M., Xing, W. and Archer, T.K. (1998) CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene, 16, 1161-1169.
35. Catteau, A., Harris, W.H., Xu, C.F. and Solomon, E. (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene, 18, 1957-1965.
36. Brown, M.A., Xu, C.F., Nicolai, H., Griffiths, B., Chambers, J.A., Black, D. and Solomon, E. (1996) The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene, 12, 2507-2513.
37. Xu, C.F., Brown, M.A., Nicolai, H., Chambers, J.A., Griffiths, B.L. and Solomon, E. (1997) Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. Hum. Mol. Genet., 6, 1057-1062.
38. Barker, F., Liu, X. and Almeida, E.R.A. (1996) The BRCA1 and IA1.3B promoters are parallel elements of a genomic duplication at 17q21. Genomics, 38, 215-222.
39. Lapidus, R.G., Nass, S.J., Butash, K.A., Parl, F.F., Weitzman, S.A., Graff, J.G., Herman, J.G. and Davidson, N.E. (1998) Mapping of ER gene CpG island methylation by methylation-specific polymerase chain reaction. Cancer Res., 58, 2515-2519.
40. Issa, J.P. Ottaviano, Y.L., Celano, P., Hamilton, S.R., Davidson, N.E. and Baylin, S.B. (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet., 1, 536-540.
41. Issa, J.P., Zehnbauer, B.A., Civin, C.I., Collector, M.I., Sharkis, S.J., Davidson, N.E., Kaufmann, S.H. and Baylin, S.B. (1996) The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res., 56, 973-77.
42. Antequera, F., Boyes, J. and Bird, A. (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62, 503-514.
43. Campbell, I.G., Nicolai, H.M., Foulkes, W.D., Senger, G., Stamp, G.W., Allan, G., Boyer, C., Jones, K., Bast, R.C. Jr and Solomon, E. (1994) A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. Hum. Mol. Genet., 3, 589-594.